WordNet

any of the salts of hydrobromic acid; formerly used as a sedative but now generally replaced by safer drugs

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Management of drooling in children: a survey of UK paediatricians' clinical practice.

Parr JR, Buswell CA, Banerjee K, Fairhurst C, Williams J, O'Hare A, Pennington L; British Academy of Childhood Disability Drooling Study Development Group.Collaborators (11)Parr JR, Pennington L, Buswell CA, Honey E, Colver A, Williams J, Fairhurst C, Cockerill H, O'Hare A, Andrew MA, Banerjee K.
Child: care, health and development.Child Care Health Dev.2012 Mar;38(2):287-91. doi: 10.1111/j.1365-2214.2011.01213.x. Epub 2011 Mar 11.
BACKGROUND: Drooling is common in children with disordered oral-motor control. There is little evidence about the comparative effectiveness of different interventions used to reduce the impact of drooling. Anecdotal reports suggest clinicians' management of drooling varies widely. The aims of this s
PMID 21392056

Pharmacokinetics of multiple inhaled NVA237 doses in patients with chronic obstructive pulmonary disease (COPD).

Sechaud R, Renard D, Zhang-Auberson L, Motte Sde L, Drollmann A, Kaiser G.SourceNovartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland. romain.sechaud@novartis.com
International journal of clinical pharmacology and therapeutics.Int J Clin Pharmacol Ther.2012 Feb;50(2):118-28.
OBJECTIVE: NVA237 (glycopyrronium bromide) is a once-daily longacting muscarinic antagonist (LAMA) in development for the treatment of chronic obstructive pulmonary disease (COPD). This study investigated the pharmacokinetics (PK) of NVA237 following single and repeated once-daily inhalation in mild
PMID 22257577